Rd Nephrologie SAS

Rd Nephrologie SAS is an SME in Montpellier, France that has taken part in 6 EU-funded projects since 2012, receiving €1.3M in EU funding.

EU funding received€1.3M
EU projects6
As coordinator0
Running now2
First EU project2012
Latest project2026
CountryFrance
EU registration (PIC)972461958
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Rd Nephrologie SAS's own share of each project, not the project's full budget.

  • Horizon Europe€998k · 3 projects
  • Horizon 2020€275k · 2 projects
  • FP7 (2007 to 2013)€10k · 1 project

Projects

6 EU-funded projects, newest first. Each links to the official record.

  • LipidBRIGHTPartner

    Lipids as promising BRidge between novel disease InsiGHts and improved Therapy

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €315ktheir share
  • PICKEDPartner

    PersonalIzed medicine in Chronic KidnEy Disease

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €283ktheir share
  • DisCo-IPartner

    Discovering Collagen I degradation process in chronic diseases with fibrotic component

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €400ktheir share
  • STRATEGY-CKDPartner

    System omics to unravel the gut-kidney axis in Chronic Kidney Disease.

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €275ktheir share
  • CaReSyAnPartner

    Combatting the CardioRenal Syndrome: towards an integrative Analysis to reduce cardiovascular burden in chronic kidney disease

    Horizon 2020 · 2018–2021 · Project on CORDIS ↗

  • PRIORITYPartner

    Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In TYpe 2 diabetic patients with normoalbuminuria

    FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

    €10ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • HIV
  • cardiovascular diseases
  • diabetes
  • diabetic nephropathy
  • entrepreneurship
  • kidney diseases
  • lipids
  • microbiology
  • oncology
  • pathology
  • personalized medicine
  • proteomics

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime